Antihypertensive effects of six calcium antagonists: Evidence from fourier analysis of 24-hour ambulatory blood pressure recordings

Current Therapeutic Research - Clinical and Experimental

Volumn 62, Issue 4, 2001, Pages 236-253

  Macchiarulo, Carmela ^a   Pieri, Riccardo ^a   Mitolo, Delia Chieppa ^a   Pirrelli, Anna ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

4 harmonic Fourier model; Ambulatory blood pressure monitoring; Blood pressure variability; Calcium channel antagonists; Chronobiology

Indexed keywords

AMLODIPINE; FELODIPINE; LERCANIDIPINE; NIFEDIPINE; VERAPAMIL;

ARTICLE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; CHRONOBIOLOGY; CIRCADIAN RHYTHM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; ESSENTIAL HYPERTENSION; FEMALE; FOURIER ANALYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL PERFORMANCE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SLOW RELEASE FORMULATION; SUSTAINED RELEASE PREPARATION; TREATMENT OUTCOME;

EID: 0035003403     PISSN: 0011393X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0011-393X(01)80008-4     Document Type: Article

References (37)

1. Relationship of 24-hour blood pressure mean and variability to severity of target-organ damage in hypertension
2. Clinical relevance of nighttime blood pressure and of daytime blood pressure variability
3. Prognostic value of 24-hour blood pressure variability
4. Association of blood pressure variability with induction of atherosclerosis in cholesterol-fed rats
5. A consensus view on the technique of ambulatory blood pressure monitoring
6. Glossary of chronobiology
7. Methods of analysis of ambulatory blood pressure data
8. Statistical analysis of circadian blood pressure recordings in controlled clinical trials
9. Circadian rhythmic aspects of human cardiovascular function: A review by chronobiologic statistical methods
10. Testing period for single cosinor: Extent of human 24-h cardiovascular "synchronization" on ordinary routine
11. Inferential statistical methods for estimating and comparing cosinor parameters
12. Usefulness of ambulatory monitoring of blood pressure in assessing antihypertensive therapy
13. Detection of a diurnal rhythm in arterial blood pressure in the evaluation of 24-hour antihypertensive therapy
14. Blood pressure monitoring for quality assessment of antihypertensive therapy
15. Long-term BP monitoring in the evaluation of antihypertensive therapy
16. Blood pressure monitoring for assessing the duration of action of antihypertensive treatment
17. Ambulatory blood pressure monitoring in the evaluation of antihypertensive treatment: Additional information from a large data base
18. Blood pressure variability, cardiovascular risk and antihypertensive treatment
19. Trough:peak ratio: The rationale behind the United States Food and Drug Administration recommendations
20. Calcium channel blockers and hypertension: Evolving perspective - 1996
21. Trough and peak effects of a single daily dose of nifedipine gastrointestinal therapeutic system (GITS) as assessed by ambulatory blood pressure monitoring
22. Nifedipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in ischaemic heart disease, hypertension and related cardiovascular disorders
23. Sustained release nifedipine formulations. An appraisal of their current uses and prospective roles in the treatment of hypertension, ischaemic heart disease and peripheral vascular disorders
24. Nifedipine gastrointestinal therapeutic system (GITS). A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in hypertension and angina pectoris
25. Amlodipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cardiovascular disease
26. Amlodipine. A reappraisal of its pharmacological properties and therapeutic use in cardiovascular disease
27. Felodipine. A review of the pharmacology and therapeutic use of the extended release formulation in cardiovascular disorders
28. Comparison of antihypertensive effect and pharmacokinetics of conventional and extended release felodipine tablets in patients with arterial hypertension
29. Ambulatory blood pressure monitoring during sustained treatment with conventional and extended-release felodipine in mild-to-moderate hypertension
30. Extended release felodipine in essential hypertension. Variations in blood pressure during whole-day continuous ambulatory recording
31. Verapamil. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension
32. Comparative efficacy, safety and pharmacokinetics of verapamil SR vs verapamil IR in hypertensive patients
33. Clinical profile of lercanidipine
34. Lercanidipine. A review of its use in hypertension
35. Circadian variation in the frequency of onset of acute myocardial infarction
36. Circadian blood pressure variations and their impact on disease
37. Circadian rhythms and coronary artery disease